» Articles » PMID: 37646878

Outcomes Following Surgical Resection of Trigeminal Schwannomas: a Systematic Review and Meta-analysis

Overview
Journal Neurosurg Rev
Specialty Neurosurgery
Date 2023 Aug 30
PMID 37646878
Authors
Affiliations
Soon will be listed here.
Abstract

Although typically benign, trigeminal schwannomas (TS) may require surgical resection when large or symptomatic and can cause significant morbidity. This study aims to summarize the literature and synthesize outcomes following surgical resection of TS. A systematic review was performed according to PRISMA guidelines. Data extracted included patient and tumor characteristics, surgical approaches, and postoperative outcomes. Odds ratios (OR) with corresponding 95% confidence intervals (CI) were used for outcome analysis. The initial search yielded 1838 results, of which 26 studies with 974 patients undergoing surgical resection of TS were included. The mean age was 42.9 years and 58.0% were female. The mean tumor diameter was 4.7 cm, with Samii type A, B, C, and D tumors corresponding to 33.4%, 15.8%, 37.2%, and 13.6%, respectively. Over a mean symptom duration of 29 months, patients presented with trigeminal hypesthesia (58.7%), headache (32.8%), trigeminal motor weakness (22.8%), facial pain (21.3%), ataxia (19.4%), diplopia (18.7%), and visual impairment (12.0%). Surgical approaches included supratentorial (61.4%), infratentorial (15.0%), endoscopic (8.6%), combined/staged (5.3%), and anterior (5.7%) or posterior (4.0%) petrosectomy. Postoperative improvement of facial pain (83.9%) was significantly greater than trigeminal motor weakness (33.0%) or hypesthesia (29.4%). The extent of resection (EOR) was reported as gross total (GTR), near total, and subtotal in 77.7%, 7.7%, and 14.6% of cases, respectively. Over a mean follow-up time of 62.6 months, recurrence/progression was noted in 7.4% of patients at a mean time to recurrence of 44.9 months. Patients with GTR had statistically significantly lower odds of recurrence/progression (OR: 0.07; 95% CI: 0.04-0.15) compared to patients with non-GTR. This systematic review and meta-analysis report patient outcomes following surgical resection of TS. EOR was found to be an important predictor of the risk of recurrence. Facial pain was more likely to improve postoperatively than facial hypesthesia. This work reports baseline rates of post-operative complications across studies, establishing benchmarks for neurosurgeons innovating and working to improve surgical outcomes for TS patients.

Citing Articles

MRI findings for the pretreatment diagnosis of small Meckel's cave tumors: comparison of meningiomas and schwannomas.

Tu Y, Wu H, Hsueh F, Tai W, Yu K, Wu C BMC Med Imaging. 2025; 25(1):57.

PMID: 39987052 PMC: 11847328. DOI: 10.1186/s12880-025-01597-1.


Management of large Trigeminal Schwannoma: long-term oncologic and functional outcome from a multicentric retrospective cohort.

Choucha A, Troude L, Morin L, Fernandes S, Baucher G, De Simone M Acta Neurochir (Wien). 2024; 166(1):440.

PMID: 39499407 DOI: 10.1007/s00701-024-06292-8.

References
1.
Bal J, Bruneau M, Berhouma M, Cornelius J, Cavallo L, Daniel R . Management of non-vestibular schwannomas in adult patients: a systematic review and consensus statement on behalf of the EANS skull base section Part II: Trigeminal and facial nerve schwannomas (CN V, VII). Acta Neurochir (Wien). 2022; 164(2):299-319. DOI: 10.1007/s00701-021-05092-8. View

2.
Sarma S, Sekhar L, Schessel D . Nonvestibular schwannomas of the brain: a 7-year experience. Neurosurgery. 2002; 50(3):437-48; discussion 438-9. DOI: 10.1097/00006123-200203000-00002. View

3.
Sato M, Kanai N, Fukushima Y, Matsumoto S, Tatsumi C, Kitamura K . Hypoglossal neurinoma extending intra- and extracranially: case report. Surg Neurol. 1996; 45(2):172-5. DOI: 10.1016/s0090-3019(96)80012-7. View

4.
MacNally S, Rutherford S, Ramsden R, Evans D, King A . Trigeminal schwannomas. Br J Neurosurg. 2008; 22(6):729-38. DOI: 10.1080/02688690802272172. View

5.
Al-Mefty O, Ayoubi S, Gaber E . Trigeminal schwannomas: removal of dumbbell-shaped tumors through the expanded Meckel cave and outcomes of cranial nerve function. J Neurosurg. 2002; 96(3):453-63. DOI: 10.3171/jns.2002.96.3.0453. View